Beiersdorf, the global skincare powerhouse behind NIVEA, has launched Eucerin, its dermatologist-recommended skincare brand, in the Nigerian market.
This innovation targets hyperpigmentation, acne, dry skin, and sun protection, leveraging honest science to sustain and restore skin health and by introducing Eucerin, Beiersdorf reaffirms its commitment to delivering science-driven skincare solutions, solidifying its position as a leader in the industry.
The launch which was held at the Marriott Hotel in Lagos also featured the unveiling of four new facial products, including Even Pigment Perfector Dual Serum, Even Pigment Perfector Day & Night Cream, Demopurifyer Triple Effect Serum, and a trio of sun protection products and a scientific a presentation by Prof. Firas Al-Niaimi, a renowned UK-based Consultant Dermatologist and Laser Specialist, and panel discussions by skin care experts.
Oladele Adeyole, Country Manager for Beiersdorf Nigeria, highlighted Eucerin’s rich dermatological heritage and commitment to efficacy and safety while emphasizing the urgent need for scientifically proven skincare solutions in Nigeria, citing NAFDAC’s 2021 warning on the dangers of unregulated bleaching products. “NAFDAC raised an alarm about the prevalent issue of bleaching in Nigeria about three years ago,” he stated. “Many people resort to bleaching as a solution to beauty problems, but today, beauty encompasses not just healthcare and well-being, but also moral responsibility that demands attention.”
READ ALSO : The Power of Women: How MTN enterprise business celebrated women who are their own boss
Mathieu Levasseur, Beiersdorf’s General Manager for Central, East, and West Africa (CEWA), expressed excitement about launching Eucerin in Nigeria, building on the company’s decade-long presence in the country through NIVEA. “We are proud to introduce Eucerin, the world’s first skincare brand backed by over 120 years of medical science and research,” he said.
Nathalie Gemayel, Regional Medical Manager for Africa and the Middle East, guided guests through Eucerin’s remarkable journey, from its inception in 1882 by Paul C. Beiersdorf and three pioneering chemists, to its arrival in Nigeria in 2024.
She highlighted the brand’s latest breakthrough with Thiamidol, a revolutionary molecule proven to effectively treat hyperpigmentation. Gemayel emphasized Eucerin’s success, noting, “We sell a product every two seconds globally because our solutions work. We remain committed to science, proof, and efficacy, having conducted over 1,000 clinical studies in just six years.”
During his keynote presentation, Prof. Al-Niaimi shed light on the emotional and physical toll of acne and skin concerns, showcasing Eucerin’s patient-centric approach. He underscored Beiersdorf’s pioneering ability to test human Tyrosinase, enabling the company to tackle hyperpigmentation at its root by inhibiting this key enzyme.
“This treatment offers a safer alternative to hydroquinone and preserves natural pigmentation without interfering with normal melanocytes or natural black skin pigment. Unlike traditional bleaching agents, it does not cause melanocyte toxicity or disrupt the skin’s natural balance. It is safe for long-term use – even during pregnancy – does not enter the bloodstream, and is targeted to treat only problem areas, making it a preferred choice among patients with Skin of Colour”, Prof. Al-Niaimi said.
Eucerin’s panel discussion, led by Prof. Al-Niaimi, brought together experts to discuss product application and effectiveness. They showcased Thiamidol as a breakthrough ingredient, outperforming 50,000 other compounds in inhibiting human Tyrosinase.
The event drew prominent dermatologists and industry professionals, signaling a new era in safe and effective skincare for African skin.
Discover more from The Industry
Subscribe to get the latest posts sent to your email.
